PF-Atlas › Clinical Trials › NCT07287670

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis

MTX-474 · Phase 2

Registry ID

NCT07287670

Phase

Phase 2

Status

Recruiting

Drug / intervention

MTX-474

Sponsor

Mediar Therapeutics

Start

2026-04-16

Enrollment

Locations

About this trial

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

View NCT07287670 on ClinicalTrials.gov →

Explore related

All MTX-474 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT07287670 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.